SK Hynix, a leading memory chip maker, plans a US listing on Nasdaq as early as August. This move aims to boost its global investor profile...

SpaceX is poised for a historic IPO, aiming to raise $75 billion with a $1.8 trillion valuation. Despite immense investor excitement and Mu...

Investors are pouring money into Artificial Intelligence, even as economic worries grow. SpaceX's massive IPO signals strong AI interest. C...

In an interview, Kim Young-hoon told Reuters that companies like Samsung Electronics that outperform profit targets should consider sharing...

Indian stock markets experienced a sharp selloff on Friday, with Sensex and Nifty dropping over 1%, driven by passive fund flows from MSCI ...

SK Hynix has crossed the $1 trillion market value mark. This milestone follows similar achievements by rivals Samsung Electronics and Micro...

South Korea's stock market saw a dramatic fall on Friday. This happened after a massive rally pushed valuations to extreme levels. The mark...

Krishna Institute of Medical Sciences (KIMS) stock has broken out of a symmetrical triangle pattern on daily charts, signaling a potential ...

South Korea is discussing sharing the wealth generated by artificial intelligence. A government official suggested distributing AI profits,...

Samsung Electronics has crossed a $1 trillion valuation. This milestone is fueled by strong demand for AI chips. The company is a major sup...

Samsung Electronics achieved record profits, fueled by a massive surge in chip income. The company anticipates a severe chip shortage next ...

Samsung Electronics posted a record quarterly profit on Thursday, driven by strong sales of chips crucial for artificial intelligence. Sout...

Samsung estimated an operating profit of 57.2 trillion won ($37.92 billion) for the January to March period, compared with an LSEG SmartEst...

Krishna Institute of Medical Sciences (KIMS) has shown a bullish uptrend over the past six months, with its stock price rallying over 40%. ...

The discount to KIMS has been assigned in comparison to the aforementioned peers on the back of high concentration risk with around 2/3rd o...

Existing promoters and shareholders will continue to hold a balance 49 per cent stake. Post-acquisition, the hospital will be renamed 'KIMS...

At the upper end of the price limit, the issue is asking for a PE multiple of 31.2 times and EV/Ebitda of 17.8 times on an FY21 basis.